SSA: Formal analysis, Writing review & editing, Writing original draft, Software, Methodology
This represents a significant breakthrough for Pfizer in the area of oral small molecule GLP-1R agonists and may also bring new treatment options for patients with obesity
If you're covered by Medicare and qualify for the Bridge Program, the $50/month FDA-approved option through a participating pharmacy may represent a materially different cost-benefit calculation than Omzo's compounded program at $199-$399 per month
It typically lasts a relatively short time and doesnt do long-term damage to the pancreas
The FDA in the United States has issued warnings about contamination and dosing inconsistencies in compounded GLP-1 products, and Health Canada has echoed similar concerns
The 12mg dose in trials showed roughly double the weight loss of the 4mg dose by week 24